Matrikine
A matrikine is a peptide fragment liberated by proteolysis of an extracellular matrix protein that then acts as a signalling molecule through cell surface receptors.
Matrikines invert the usual picture of the matrix as inert scaffolding. When metalloproteinases, elastases, or cathepsins cleave a structural protein, they can expose or release short sequences that cells recognise through integrins, G protein-coupled receptors, or dedicated receptor complexes. Matricryptin is the term used when the active site is buried until cleavage exposes it. This makes the matrix a stored record of its own damage: degradation generates the signals that direct the response.
The best-characterised example is VGVAPG, a hexapeptide repeat within elastin that binds the elastin receptor complex, acting as a chemoattractant and inducing further elastase expression. Endostatin, a fragment of collagen XVIII, inhibits angiogenesis. In cosmetics the reference case is palmitoyl pentapeptide-4, carrying the sequence KTTKS, a subfragment of the carboxy-terminal propeptide of type I procollagen; a palmitoyl chain is added to raise lipophilicity, which also pushes its molecular weight to roughly eight hundred daltons.
The concept is genuinely useful because it explains how a peptide of only a few residues could have a specific effect at low concentration: it is a sequence the tissue already interprets as feedback. The same logic imposes a limit: matrikine signalling is context-dependent, so one fragment can promote repair in one setting and degradation in another, depending on receptor availability and cell state.
The marketing error is treating every matrix-derived fragment as a build signal. Elastin-derived matrikines mostly signal damage and can drive further elastolysis and inflammatory recruitment rather than fibre synthesis. And receptor binding in culture establishes that the peptide is active if it arrives, a separate question from whether a topically applied, lipid-modified version arrives at all.